DGX - Quest Corp Debt to Book Capitalization Ratio

Graphic logo of Quest Diagnostics (DGX)

The ratio of total liabilities to book capitalization visualizes the financial stability of Quest Diagnostics (DGX), where 0.80 determines the current status of the parameter. The company's extensive laboratory network guarantees predictable cash flow and crisis-resistant demand. Revenues are based on insurance payouts and patient visits. Disciplined management strengthens investor confidence by developing the profitable molecular sector and effectively integrating regional assets.

Quest Diagnostics - DGX Debts to Book Capitalization (period 07/04/2022 - 10/27/2026)
Flagship merchandise of Quest

Jim Davis's strategy for expanding the Quest Diagnostics (DGX) network through the acquisition of regional laboratories requires precise control over debt load. Analyzing the company's balance sheet financial leverage, an investor observes the dynamics of the total liabilities-to-equity ratio, where a declining coefficient confirms the business's growing solvency, although it may limit return on equity by reducing the leverage ratio.

Who Quest Diagnostics competes with

Debts to Book Capitalization A (Agilent Technologies)|illumina.com - Debts to Book Capitalization|Exact Sciences Corporation (EXAS) - Debt to Book Capitalization Ratio|RVTY - Debt to Book Value Ratio|BIO: Debts to Book Capitalization|NNNN (Anbio Corp) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Sotera Health Company|Debt to Book Capitalization Ratio quidel.com (QDEL)|OPKO Health - Debt to Book Value|Debts to Book Value CDNA (CareDx, Inc)|Debt to Book Capitalization Ratio MRVI|Debts to Net Assets Fulgent FLGT|Debts to Book Capitalization LAB (Standard BioTools Inc.)|CTKB: Debts to Net Assets|OraSure - Debt to Book Capitalization Ratio|XGN (Exagen) - Debts to Net Assets|MDxHealth Inc. - Debt to Book Capitalization Ratio|Debt to Net Assets Lucid Diagnostics, Inc (LUCD)|Debt to Book Value PRE|Debts to Book Capitalization imdxinc.com (IMDX)|TRIB: Debts to Book Capitalization|ProPhase Labs Inc - Debts to Book Value|Debt to Book Capitalization Ratio AIMD (Ainos Corp)|CoDx (CODX) - Debts to Net Assets|HSCS - Debt to Book Value|Debt to Book Capital biomerica.com|CDIO - Debt to Book Value|Debt to Net Assets Ratio Virax Biolabs Group Limited|Debts to Book Capitalization Bluejay BJDX|Debt to Book Value Ratio Aspira Women's Health Inc (AWH)|Debts to Book Capitalization AXDX|Debts to Net Assets centogene.com CNTG|Enzo - Debts to Book Capitalization|FRES - Debts to Book Capitalization|Debts to Book Capitalization GENE (gtglabs.com)|ME (23andMe Inc) - Debt to Net Assets|Debt to Book Capitalization Ratio Psychemedics (PMD)